Cargando…
EPH154 Assessment of Performance Characteristics of COVID-19 ICD-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the US FDA Best Network
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232824/ http://dx.doi.org/10.1016/j.jval.2022.04.905 |
| _version_ | 1784735682897379328 |
|---|---|
| author | Moll, K Hobbi, S Zhou, CK Fingar, K Burrell, T Hernandez-Medina, V Alawar, N Anderson, SA Wong, HL Obidi, J Shoaibi, A |
| author_facet | Moll, K Hobbi, S Zhou, CK Fingar, K Burrell, T Hernandez-Medina, V Alawar, N Anderson, SA Wong, HL Obidi, J Shoaibi, A |
| author_sort | Moll, K |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9232824 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92328242022-06-27 EPH154 Assessment of Performance Characteristics of COVID-19 ICD-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the US FDA Best Network Moll, K Hobbi, S Zhou, CK Fingar, K Burrell, T Hernandez-Medina, V Alawar, N Anderson, SA Wong, HL Obidi, J Shoaibi, A Value Health Article Published by Elsevier Inc. 2022-07 2022-06-25 /pmc/articles/PMC9232824/ http://dx.doi.org/10.1016/j.jval.2022.04.905 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Moll, K Hobbi, S Zhou, CK Fingar, K Burrell, T Hernandez-Medina, V Alawar, N Anderson, SA Wong, HL Obidi, J Shoaibi, A EPH154 Assessment of Performance Characteristics of COVID-19 ICD-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the US FDA Best Network |
| title | EPH154 Assessment of Performance Characteristics of COVID-19 ICD-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the US FDA Best Network |
| title_full | EPH154 Assessment of Performance Characteristics of COVID-19 ICD-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the US FDA Best Network |
| title_fullStr | EPH154 Assessment of Performance Characteristics of COVID-19 ICD-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the US FDA Best Network |
| title_full_unstemmed | EPH154 Assessment of Performance Characteristics of COVID-19 ICD-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the US FDA Best Network |
| title_short | EPH154 Assessment of Performance Characteristics of COVID-19 ICD-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the US FDA Best Network |
| title_sort | eph154 assessment of performance characteristics of covid-19 icd-10-cm diagnosis code u07.1 using sars-cov-2 nucleic acid amplification test results in the us fda best network |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232824/ http://dx.doi.org/10.1016/j.jval.2022.04.905 |
| work_keys_str_mv | AT mollk eph154assessmentofperformancecharacteristicsofcovid19icd10cmdiagnosiscodeu071usingsarscov2nucleicacidamplificationtestresultsintheusfdabestnetwork AT hobbis eph154assessmentofperformancecharacteristicsofcovid19icd10cmdiagnosiscodeu071usingsarscov2nucleicacidamplificationtestresultsintheusfdabestnetwork AT zhouck eph154assessmentofperformancecharacteristicsofcovid19icd10cmdiagnosiscodeu071usingsarscov2nucleicacidamplificationtestresultsintheusfdabestnetwork AT fingark eph154assessmentofperformancecharacteristicsofcovid19icd10cmdiagnosiscodeu071usingsarscov2nucleicacidamplificationtestresultsintheusfdabestnetwork AT burrellt eph154assessmentofperformancecharacteristicsofcovid19icd10cmdiagnosiscodeu071usingsarscov2nucleicacidamplificationtestresultsintheusfdabestnetwork AT hernandezmedinav eph154assessmentofperformancecharacteristicsofcovid19icd10cmdiagnosiscodeu071usingsarscov2nucleicacidamplificationtestresultsintheusfdabestnetwork AT alawarn eph154assessmentofperformancecharacteristicsofcovid19icd10cmdiagnosiscodeu071usingsarscov2nucleicacidamplificationtestresultsintheusfdabestnetwork AT andersonsa eph154assessmentofperformancecharacteristicsofcovid19icd10cmdiagnosiscodeu071usingsarscov2nucleicacidamplificationtestresultsintheusfdabestnetwork AT wonghl eph154assessmentofperformancecharacteristicsofcovid19icd10cmdiagnosiscodeu071usingsarscov2nucleicacidamplificationtestresultsintheusfdabestnetwork AT obidij eph154assessmentofperformancecharacteristicsofcovid19icd10cmdiagnosiscodeu071usingsarscov2nucleicacidamplificationtestresultsintheusfdabestnetwork AT shoaibia eph154assessmentofperformancecharacteristicsofcovid19icd10cmdiagnosiscodeu071usingsarscov2nucleicacidamplificationtestresultsintheusfdabestnetwork |